Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection. (Q51050741)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

author name string

O Haigh

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

J Kattenbelt

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

M Cochrane

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

S Thomson

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

A Gould

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

R Tindle

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

publication date

11 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

17

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

10

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

708-720

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

https://scigraph.springernature.com/pub.10.1038/cgt.2010.27

0 references

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

The coming of age of tumour immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Progress in human tumour immunology and immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Alternative processing of endogenous or exogenous antigens extends the immunogenic, H-2 class I-restricted peptide repertoire

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Role of transfection in the priming of cytotoxic T-cells by DNA-mediated immunization

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

DNA vaccines: precision tools for activating effective immunity against cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Prevention of cervical cancer through papillomavirus vaccination

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Immune evasion in human papillomavirus-associated cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Vaccination for treatment and prevention of cancer in animal models.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Improved immunogenicity of HIV-1 epitopes in HBsAg chimeric DNA vaccine plasmids by structural mutations of HBsAg

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Novel pathways of antigen presentation for the maintenance of memory.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

The role of the downstream signal sequences in the maturation of the HBV middle surface glycoprotein: development of a novel therapeutic vaccine candidate

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

The original sin of killer T cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

CD8+ T cell efficacy in vaccination and disease

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

The lymphatic spread of carcinoma of the cervix and of the body of the uterus; a study of 420 necropsies

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary immunisation with high-dose heterologous peptide leads to CD8 T cell populations with reduced functional avidity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CGT.2010.27

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51050741&oldid=1455609467"